Phoenix is emerging as one of the most compelling stories in the global health-tech and semiconductor race. Once seen as a secondary market, the city has strategically repositioned itself through long-term planning, ecosystem-building, and landmark investments like TSMC’s $165B+ U.S. campus.
At BIO International Convention 2025, GeneOnline spoke with Claudia Whitehead, Bioscience Healthcare Program Manager at the City of Phoenix, who offered insight into the city’s transformation. By integrating life sciences, digital health, advanced chips, and clinical innovation, Phoenix is creating an innovation stack that few regions can match. Institutions like the Phoenix Bioscience Core and Mayo Clinic’s Discovery Oasis, combined with cross-sector collaboration and international partnerships, are driving breakthroughs in precision medicine, biosensors, AI, and more.
Phoenix isn’t just welcoming the future—it’s building the infrastructure to lead it.
Read the full article here — https://bit.ly/453VF6F
